Trials / Conditions / Metastatic Small Intestinal Adenocarcinoma
Metastatic Small Intestinal Adenocarcinoma
4 registered clinical trials studyying Metastatic Small Intestinal Adenocarcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Trea NCT04729322 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers NCT04205968 | SWOG Cancer Research Network | Phase 2 |
| Completed | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors NCT03108131 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and NCT02949219 | Academic and Community Cancer Research United | Phase 2 |